News

manilatimes6d
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
Engages with Cytel's Machine Learning Technology on Data Analysis and Phase 3 Trial Design GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial” or the ...
C&EN4d
Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...
BioSpace6d
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
Engages with Cytel’s Machine Learning Technology on Data Analysis and Phase 3 Trial Design GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the ...